INIS
patients
100%
nervous system diseases
83%
brain
51%
stimulation
45%
symptoms
23%
nuclei
20%
assessments
19%
fatigue
19%
motors
18%
surgery
17%
therapy
17%
diseases
16%
performance
14%
reviews
12%
covid-19
12%
people
11%
data
11%
refractories
11%
interventions
10%
hospitals
9%
side effects
8%
psychological behavior
8%
quality of life
7%
titanium carbides
7%
design
7%
machine learning
7%
comparative evaluations
7%
management
6%
nmr imaging
6%
levels
6%
Keyphrases
Parkinson's Disease
59%
Deep Brain Stimulation
25%
Parkinson Patients
20%
Subthalamic nucleus Deep Brain Stimulation (STN-DBS)
20%
Cognitive Impairment
18%
Patients with Parkinson's Disease
17%
Cognitive Function
13%
Multiple Sclerosis
12%
Tourette Syndrome
12%
Randomized Controlled Trial
11%
Executive Function
11%
Subthalamic nucleus
11%
Cognitive Complaints
9%
Huntington's Disease
9%
Neuropsychological Tests
8%
Cognitive Domains
7%
After Surgery
7%
Quality of Life
7%
Cognitive Outcome
6%
Obsessive-compulsive Disorder
6%
Disease Severity
6%
Cognitive Training
6%
Cognitive Phenotype
6%
Cognitively Intact
6%
Cognitive Decline
5%
Cerebral Small Vessel Disease (cSVD)
5%
Cognitive Performance
5%
COVID-19
5%
Lacunar Stroke
5%
Anxiety Scale
5%